Outlook Therapeutics (OTLK) Change in Inventory (2024 - 2026)
Outlook Therapeutics (OTLK) reported Change in Inventory of -$113822.0 for Q1 2026, down 122.99% year-over-year from $495134.0 in Q1 2025, and down 195.12% quarter-over-quarter from $119660.0 in Q4 2025.
Outlook Therapeutics (OTLK) Change in Inventory (2024 - 2026) Analysis & Trends
Outlook Therapeutics (OTLK) has 3 years of Change in Inventory data on file, last reported at -$113822.0 in Q1 2026.
- Change in Inventory for Q1 2026 came in at -$113822.0, down 122.99% year-over-year; the trailing twelve-month figure through Mar 2026 was -$260289.0 (changed N/A YoY), and the FY2025 annual result was $3.3 million, changed N/A from the prior year.
- Change in Inventory fell to -$113822.0 in Q1 2026 per OTLK's latest filing, from $119660.0 in the prior quarter.
- Over five years, Change in Inventory peaked at $3.1 million in Q4 2024 and troughed at -$788312.0 in Q3 2025.
- A 3-year average of $557373.7 and a median of $307397.0 in 2025 frame the typical range for Change in Inventory.
- The sharpest annual moves came in 2025 and 2026: Change in Inventory slumped 96.15% in 2025, then tumbled 122.99% in 2026.
- A 3-year view of Change in Inventory shows it stood at $3.1 million in 2024, then tumbled by 96.15% to $119660.0 in 2025, then sank by 195.12% to -$113822.0 in 2026.
- Business Quant data shows OTLK's Change in Inventory at -$113822.0 in Q1 2026, $119660.0 in Q4 2025, and -$788312.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change Inventory (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - | - |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - | - |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - | 51,468.00 |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn | - |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - | - |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - | - |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn | 97.70 Mn |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - | - |
| 10 | Outlook Therapeutics | 51.56 Mn | 43.81 Mn | -21,888.00 | -113,822.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -113,822.00 |
| Mar 31, 2026 | -113,822.00 |
| Dec 31, 2025 | 119,660.00 |
| Dec 31, 2025 | 119,660.00 |
| Sep 30, 2025 | -788,312.00 |
| Sep 30, 2025 | -788,312.00 |
| Jun 30, 2025 | 522,185.00 |
| Jun 30, 2025 | 522,185.00 |
| Mar 31, 2025 | 495,134.00 |
| Mar 31, 2025 | 495,134.00 |
| Dec 31, 2024 | 3.11 Mn |
| Dec 31, 2024 | 3.11 Mn |